Flexibility is key in treating children with type 1 diabetes

Blood vessels

People with type 1 diabetes cannot produce their own insulin, leading to uncontrolled blood sugar levels. To survive, they must receive insulin treatment. A recently developed, long-lasting insulin called degludec offers a unique level of flexibility. This means that it is particularly suitable for treating children and young people with type 1 diabetes. Dr Nandu Thalange, an expert in childhood diabetes […]

Read More…

Diabetes treatment: Could carbonates be an alternative?

Diabetes testing

Diabetes affects millions of adults worldwide and is still a disease without a cure. While injections of insulin can help manage symptoms, there are currently no therapies to treat the underlying cause of diabetes. However, Dr Kenji Sorimachi has found that perhaps the answer lies in the form of carbonate complexes that show an ability to metabolise carbohydrates into glucose […]

Read More…

Testing in silkworms provides preventative diabetes treatment

Testing in silkworms provides preventative diabetes treatment

Diabetes is a common and life-long condition. The number of people diagnosed with diabetes has reached epidemic proportions worldwide. The search for new therapy to treat diabetes has taken an unlikely twist and led to the discovery of a potential benefit in silkworms. The silkworm is an economically important insect known for producing silk, however, Dr Yasuhiko Matsumoto and his […]

Read More…

Nuts about nuts: The Mediterranean solution to diabetes control

Professor David Jenkins and his team at The University of Toronto investigate the impacts of exchanging carbohydrates for mixed nuts – a source of unsaturated fats – on critical risk factors for cardiovascular disease, such as low-density lipoprotein particle size and apolipoprotein B levels. They also discern that adopting a lower-carb, high-fat diet, reminiscent of the Mediterranean diet, increases glycaemic […]

Read More…

Could stem cells offer a viable treatment for retinopathy?

BetaStem Therapeutics research outreach

Diabetes is a growing global epidemic, with over 400 million affected and cases expected to double in the next 10 years. Retinopathy, or damage to the blood vessels in the retina, occurs in most patients with type 1 diabetes and 75 per cent of patients with type 2 diabetes, leading to vision loss for many. BetaStem Therapeutics is a stem […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at audience@researchoutreach.org at any time and if you have any questions about how we handle your data, please review our privacy agreement.

 I would like to receive updates about:

By selecting any of the topic options below you are consenting to receive email communications from us about these topics.

I consent to receiving promoted content:

We are able share your email address with third parties (such as Google, Facebook and Twitter) in order to send you promoted content which is tailored to your interests as outlined above. If you are happy for us to contact you in this way, please tick below.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION